|

Topotecan Hydrochloride for Injection Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 2

Top Sponsors

  • MediLink Therapeutics (Suzhou) Co., Ltd.1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Cancer2
  • Ovarian Cancer1
  • Small Cell Lung Cancer1
  • Lung Cancer1

Other2 trials

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
Phase 3
A Study of SHR-A1811 in Subjects With Ovarian Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.